Decreased hippocampal volume is a biomarker of Alzheimer disease (AD). The association of hippocampal volume with gait variability across the spectrum of AD, especially in early stages, has been few studied. The study aims to examine the association of hippocampal volume with the coefficient of variation (CoV) of stride time in individuals with mild and moderate to severe subjective cognitive impairment (SCI), non-amnestic mild cognitive impairment (na-MCI), amnestic mild cognitive impairment (a-MCI), and mild to moderate AD dementia
Gait disturbances are some of the earliest changes in dementia and their monitoring presents an oppo...
Background: Gait analysis with accelerometers is a relatively inexpensive and easy to use method to ...
Gait disturbances are some of the earliest changes in dementia and their monitoring presents an oppo...
Decreased hippocampal volume is a biomarker of Alzheimer disease (AD). The association of hippocampa...
Background: Decreased hippocampal volume is a biomarker of Alzheimer disease (AD). The association o...
In contrast to its prominent function in cognition, the involvement of the hippocampus in gait contr...
BACKGROUND: In contrast to its prominent function in cognition, the involvement of the hippocampus i...
Gait impairment is observed in early stages of dementia, such as mild cognitive impairment (MCI), an...
International audienceAlthough gait disorders are common in Alzheimer's disease (AD), determining wh...
International audienceDifferences in brain structures involved in gait control between normal and pa...
Increased stride time variability has been associated with memory impairment in mild cognitive impai...
The differences in gait abnormalities from the earliest to the later stages of dementia and in the d...
The main aim of the present study was to compare volume differences in the hippocampus and parahippo...
International audienceThe interpretation of the increase in stride-to-stride variability of stride t...
Aims:To assess the correlation between cognitive functioning and 3 gait parameters (gait speed, cade...
Gait disturbances are some of the earliest changes in dementia and their monitoring presents an oppo...
Background: Gait analysis with accelerometers is a relatively inexpensive and easy to use method to ...
Gait disturbances are some of the earliest changes in dementia and their monitoring presents an oppo...
Decreased hippocampal volume is a biomarker of Alzheimer disease (AD). The association of hippocampa...
Background: Decreased hippocampal volume is a biomarker of Alzheimer disease (AD). The association o...
In contrast to its prominent function in cognition, the involvement of the hippocampus in gait contr...
BACKGROUND: In contrast to its prominent function in cognition, the involvement of the hippocampus i...
Gait impairment is observed in early stages of dementia, such as mild cognitive impairment (MCI), an...
International audienceAlthough gait disorders are common in Alzheimer's disease (AD), determining wh...
International audienceDifferences in brain structures involved in gait control between normal and pa...
Increased stride time variability has been associated with memory impairment in mild cognitive impai...
The differences in gait abnormalities from the earliest to the later stages of dementia and in the d...
The main aim of the present study was to compare volume differences in the hippocampus and parahippo...
International audienceThe interpretation of the increase in stride-to-stride variability of stride t...
Aims:To assess the correlation between cognitive functioning and 3 gait parameters (gait speed, cade...
Gait disturbances are some of the earliest changes in dementia and their monitoring presents an oppo...
Background: Gait analysis with accelerometers is a relatively inexpensive and easy to use method to ...
Gait disturbances are some of the earliest changes in dementia and their monitoring presents an oppo...